Virogen Biotechnology — Stock, Pipeline & Market Cap

Is this your company? Claim your profile to update info and connect with investors.

Private Company

Funding information not available

Overview

ViroGen Biotechnology is a well-established, privately-held reagent and service provider operating at the intersection of research tools and infectious disease diagnostics. With a foundation dating back to 1995, the company leverages expertise in recombinant protein and antibody production to supply a catalog of critical reagents for pathogens like HIV, Hepatitis, Lyme disease, SARS-CoV-2, and Influenza. Its business model combines product sales with high-margin custom services, positioning it as a specialized partner for academic, biopharma, and diagnostic manufacturing clients globally.

Infectious Disease

Technology Platform

Recombinant protein and antibody production platform for generating antigens, monoclonal/polyclonal antibodies, and single-chain variable fragments (scFv) for research and diagnostics.

Opportunities

Growing demand for high-quality, characterized reagents for diagnostic test manufacturing, especially for infectious diseases.

The custom service business offers higher margins and sticky client relationships.

Continuous need for reagents targeting emerging pathogens and variants provides a pipeline for new catalog products.

Risk Factors

Intense competition from large, global life science suppliers with greater sales and marketing resources.

Dependency on research funding cycles and shifting public health priorities.

Operational risks related to bioproduction consistency and supply chain for raw materials.

Competitive Landscape

ViroGen competes in a fragmented but competitive market dominated by giants like Thermo Fisher Scientific and Merck, who offer broad portfolios. It differentiates through deep expertise in infectious disease antigens, custom service capabilities, and a focus on the diagnostic manufacturing niche. Other competitors include specialized antibody companies and regional reagent suppliers.

More companies in Biologics / Biosimilars →More companies in United States →